62 related articles for article (PubMed ID: 2134043)
21. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease].
Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L
Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG
J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285
[TBL] [Abstract][Full Text] [Related]
23. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
[TBL] [Abstract][Full Text] [Related]
24. [T lymphocyte subsets in alveolar lavage and peripheral blood in sarcoidosis and extrinsic allergic alveolitis].
Desrues B; Delaval P; Genetet N; Kernec J; Pencolé C; Merdrignac G; Cornillet B; Genetet B
Pathol Biol (Paris); 1987 Dec; 35(10):1301-8. PubMed ID: 2963992
[TBL] [Abstract][Full Text] [Related]
25. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.
Agostini C; Trentin L; Facco M; Sancetta R; Cerutti A; Tassinari C; Cimarosto L; Adami F; Cipriani A; Zambello R; Semenzato G
J Immunol; 1996 Jul; 157(2):910-8. PubMed ID: 8752945
[TBL] [Abstract][Full Text] [Related]
26. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases.
Zissel G; Ernst M; Schlaak M; Müller-Quernheim J
J Investig Med; 1997 Feb; 45(2):75-86. PubMed ID: 9084578
[TBL] [Abstract][Full Text] [Related]
27. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
28. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis.
Kline JN; Schwartz DA; Monick MM; Floerchinger CS; Hunninghake GW
Chest; 1993 Jul; 104(1):47-53. PubMed ID: 8325116
[TBL] [Abstract][Full Text] [Related]
29. The role of T-lymphocyte subpopulation in bronchoalveolar lavage in pulmonary parenchyma diseases.
Bencic D; Batinic D; Cucevic I; Boranic M; Miculinic N
Sarcoidosis; 1990 Sep; 7(2):106-9. PubMed ID: 2255784
[TBL] [Abstract][Full Text] [Related]
30. Clinical and biochemical aspects of sarcoidosis. With special reference to angiotensin-converting enzyme (ACE).
Rømer FK
Acta Med Scand Suppl; 1984; 690():3-96. PubMed ID: 6097101
[TBL] [Abstract][Full Text] [Related]
31. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
32. [Methylation of membrane phospholipids of alveolar macrophages in pulmonary sarcoidosis and diffuse interstitial pulmonary fibrosis].
Pacheco Y; Fonlupt P; Dubois M; Biot N; Perrin-Fayolle M; Pacheco H
Pathol Biol (Paris); 1986 Dec; 34(10):1067-73. PubMed ID: 3547262
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
Hunninghake GW; Crystal RG
J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
[TBL] [Abstract][Full Text] [Related]
34. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
Hunninghake GW
Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis.
Martinet Y; Pinkston P; Saltini C; Spurzem J; Müller-Quernheim J; Crystal RG
Am Rev Respir Dis; 1988 Nov; 138(5):1242-8. PubMed ID: 3264483
[TBL] [Abstract][Full Text] [Related]
36. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases.
Nagai S; Aung H; Takeuchi M; Kusume K; Izumi T
Chest; 1991 Mar; 99(3):674-80. PubMed ID: 1995225
[TBL] [Abstract][Full Text] [Related]
37. [Hyalinosis in generalized sarcoidosis located primarily in the lungs simulating a tumor].
Dobiás J; Blazková E
Sb Lek; 1991 Mar; 93(1-2):41-6. PubMed ID: 2047742
[TBL] [Abstract][Full Text] [Related]
38. [T-lymphocytes disorders in pulmonary sarcoidosis].
Gormand F; Ecochard D; Aloui R; Perrin-Fayolle M; Pacheco Y
Rev Mal Respir; 1990; 7(3):187-94. PubMed ID: 1694590
[TBL] [Abstract][Full Text] [Related]
39. Histochemical evaluation of lung collagen content in acute and chronic interstitial diseases.
Saldiva PH; Delmonte VC; de Carvalho CR; Kairalla RA; Auler Júnior JO
Chest; 1989 May; 95(5):953-7. PubMed ID: 2468455
[TBL] [Abstract][Full Text] [Related]
40. Diffuse interstitial pneumonitis and fibrosis in sarcoidosis.
Aisner SC; Albin RJ
Chest; 1988 Jul; 94(1):193-5. PubMed ID: 3383632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
